Major Adverse Liver Outcomes
Cross-source consensus on Major Adverse Liver Outcomes from 1 sources and 7 claims.
1 sources · 7 claims
Risks & contraindications
Comparisons
Other
Highlighted claims
- MALO was defined as serious liver complications or end-stage manifestations of liver disease, encompassing acute liver failure, cirrhosis, portal hypertension, cholangitis, ascites, variceal bleeding, portal vein thrombosis, and hepatocellular carcinoma. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
- African American patients had 1.42 times the adjusted odds of MALO compared with white patients. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
- Patients aged 50 years or older had more than twice the adjusted odds of MALO. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
- Female sex was independently associated with significantly lower odds of MALO. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
- Coronary artery disease and sepsis were significant independent clinical correlates of MALO. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
- Cholangitis was the most common MALO event among African American patients at 6.77%, markedly higher than in other racial groups. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
- Patients in the lowest income quartile had 19% higher adjusted odds of MALO than those in the highest quartile. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample